Patrick F. Williams - 12 Mar 2024 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Chief Financial Officer
Signature
/s/ Nathaniel Sisitsky as attorney-in-fact for Patrick F. Williams
Issuer symbol
STAA
Transactions as of
12 Mar 2024
Net transactions value
$0
Form type
4
Filing time
14 Mar 2024, 17:14:44 UTC
Previous filing
11 Mar 2024
Next filing
19 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Restricted Stock Units Award $0 +24,460 $0.000000 24,460 12 Mar 2024 Common Stock 24,460 $0.000000 Direct F1, F2
transaction STAA Common Stock Options Award $0 +21,908 $0.000000 21,908 12 Mar 2024 Common Stock 21,908 $37.64 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.
F2 RSUs granted to the Reporting Person on March 12, 2024. RSUs will vest as to 1/3 (8,153 shares) on March 12, 2025, 1/3 (8,153 shares) on March 12, 2026, and 1/3 (8,154 shares) on March 12, 2027.
F3 Stock options granted to the Reporting Person on March 12, 2024. Options will vest and become exercisable as to 1/3 (7,302 shares) on March 12, 2025, with the remaining 2/3 (14,606 shares) vesting and becoming exercisable monthly over the following 24 months in equal amounts on a monthly basis. In the event such amount does not evenly divide into 24 months, the remaining balance of options will vest and become exercisable on March 12, 2027.